Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 2401-2450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07116187
A Pilot Return-to-Work Cognitive Intervention After Stroke
NARecruiting
100 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07124208
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
NARecruiting
46 participants
Started: Aug 8, 2025 · Completed: Aug 15, 2026
1 condition1 sponsor2 locations
NCT07001384
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
PHASE1Recruiting
30 participants
Started: Aug 8, 2025 · Completed: Aug 8, 2031
2 conditions3 sponsors7 locations
NCT07141303
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
PHASE3Recruiting
1,060 participants
Started: Aug 8, 2025 · Completed: Jun 30, 2028
1 condition6 sponsors1 location
NCT07100158
Ultrasonographic Optic Nerve Sheath Diameter in Postdural Puncture Headache Diagnosis
N/ARecruiting
190 participants
Started: Aug 8, 2025 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT06948565
Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study
N/ARecruiting
500 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT07039591
Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA
EARLY_PHASE1Recruiting
60 participants
Started: Aug 8, 2025 · Completed: Oct 30, 2026
1 condition2 sponsors1 location
NCT07072832
Shelf Acetabuloplasty With 3D Printed Implants as a New Treatment for Symptomatic Adult Hip Dysplasia
NARecruiting
10 participants
Started: Aug 8, 2025 · Completed: Feb 29, 2028
1 condition1 sponsor1 location
NCT06974786
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
PHASE2Recruiting
100 participants
Started: Aug 8, 2025 · Completed: Apr 30, 2033
2 conditions3 sponsors3 locations
NCT07099911
Neuromuscular Electrical Stimulation and Glucose Control in Spinal Cord Injury
NARecruiting
20 participants
Started: Aug 8, 2025 · Completed: Sep 1, 2027
1 condition2 sponsors1 location
NCT06912763
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
PHASE2Recruiting
250 participants
Started: Aug 8, 2025 · Completed: Mar 1, 2033
4 conditions1 sponsor1 location
NCT07172516
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
PHASE3Recruiting
400 participants
Started: Aug 8, 2025 · Completed: Aug 31, 2028
4 conditions1 sponsor9 locations
NCT07031531
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
NARecruiting
4,900 participants
Started: Aug 8, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor16 locations
NCT07099001
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay
NARecruiting
150 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT07170644
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
PHASE2Recruiting
18 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2030
2 conditions1 sponsor2 locations
NCT06168058
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
NARecruiting
40 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2026
5 conditions4 sponsors3 locations
NCT06691243
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
PHASE2Recruiting
40 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors2 locations
NCT06892093
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
NARecruiting
308 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT07098351
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
NARecruiting
93 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT07067567
A Study of AK146D1 for Injection in Advanced Solid Tumors
PHASE1Recruiting
200 participants
Started: Aug 7, 2025 · Completed: May 5, 2027
1 condition1 sponsor1 location
NCT07153159
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
PHASE1Recruiting
8 participants
Started: Aug 7, 2025 · Completed: Oct 12, 2026
1 condition1 sponsor1 location
NCT06692192
The RECAP2 Study: Midazolam and Psilocybin
PHASE1Recruiting
60 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT07162181
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
PHASE2Recruiting
13 participants
Started: Aug 7, 2025 · Completed: May 31, 2030
3 conditions1 sponsor6 locations
NCT06981325
Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
PHASE2Recruiting
34 participants
Started: Aug 7, 2025 · Completed: Jul 31, 2029
2 conditions4 sponsors5 locations
NCT06963736
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time
NARecruiting
30 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT07079865
Effect of 60-day Peripheral Nerve Stimulation (PNS) in Alleviating Pain and Improving Function After Acute Thoracolumbar Compression Fracture
N/ARecruiting
15 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors3 locations
NCT07023289
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
PHASE2Recruiting
140 participants
Started: Aug 7, 2025 · Completed: Nov 30, 2029
1 condition1 sponsor17 locations
NCT07091032
Building Connections
NARecruiting
3,600 participants
Started: Aug 7, 2025 · Completed: Dec 30, 2029
4 conditions1 sponsor1 location
NCT06792825
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
PHASE2Recruiting
65 participants
Started: Aug 7, 2025 · Completed: Jul 8, 2031
2 conditions2 sponsors1 location
NCT06556121
Saddle Block With IT Morphine for Penile Inversion Vaginoplasty
NARecruiting
40 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06815471
CRF2 Agonist for the Treatment of Worsening Heart Failure
PHASE2Recruiting
300 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors10 locations
NCT06967324
GRACE - Graduated Response for Advanced COPD With Enhanced Support
NARecruiting
100 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT07050433
Correlate Biomarkers for the SYNERGY- 201 Study
N/ARecruiting
48 participants
Started: Aug 7, 2025 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT06854159
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
PHASE2Recruiting
34 participants
Started: Aug 7, 2025 · Completed: Apr 30, 2029
4 conditions2 sponsors1 location
NCT07102836
COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY
PHASE2Recruiting
110 participants
Started: Aug 7, 2025 · Completed: May 7, 2026
2 conditions1 sponsor1 location
NCT07122245
Demographics of Lung Cancer in Females
N/ARecruiting
300 participants
Started: Aug 7, 2025 · Completed: Apr 7, 2026
1 condition1 sponsor1 location
NCT07094425
Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study
N/ARecruiting
50 participants
Started: Aug 7, 2025 · Completed: Nov 1, 2026
2 conditions2 sponsors2 locations
NCT07124520
A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) Tongue Strength Trainer in People With Oral Tongue Cance
NARecruiting
60 participants
Started: Aug 7, 2025 · Completed: Aug 7, 2028
1 condition1 sponsor7 locations
NCT06896916
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
135 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2036
1 condition1 sponsor14 locations
NCT07098338
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
278 participants
Started: Aug 7, 2025 · Completed: Apr 6, 2029
1 condition2 sponsors57 locations
NCT06825403
Olfactory Training in Mild Cognitive Impairment
NARecruiting
30 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT06918119
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
NARecruiting
30 participants
Started: Aug 7, 2025 · Completed: Jul 31, 2030
2 conditions1 sponsor1 location
NCT07007793
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
PHASE3Recruiting
180 participants
Started: Aug 7, 2025 · Completed: Feb 18, 2028
1 condition1 sponsor88 locations
NCT06865339
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
PHASE2Recruiting
76 participants
Started: Aug 7, 2025 · Completed: Aug 31, 2027
2 conditions5 sponsors1 location
NCT06732401
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
PHASE3Recruiting
630 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2028
4 conditions1 sponsor116 locations
NCT06923462
VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)
NARecruiting
100 participants
Started: Aug 6, 2025 · Completed: Mar 15, 2028
2 conditions1 sponsor1 location
NCT07158918
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
65 participants
Started: Aug 6, 2025 · Completed: Dec 2, 2027
1 condition2 sponsors6 locations
NCT06712927
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
PHASE2Recruiting
60 participants
Started: Aug 6, 2025 · Completed: Feb 28, 2030
2 conditions1 sponsor1 location
NCT06655207
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage
NARecruiting
1,000 participants
Started: Aug 6, 2025 · Completed: Jul 30, 2026
3 conditions3 sponsors7 locations
NCT07027072
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
PHASE2Recruiting
114 participants
Started: Aug 6, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor8 locations